Alcyone Lifesciences recently obtained Breakthrough Device Designation from the FDA for their novel implantable intrathecal bolus drug delivery catheter and port system, the ThecaFlex DRx System. The system is intended for use in conditions that require prolonged medication administration directly into the cerebrospinal fluid (CSF), such as some c (Read more...)